Clinical Trial Update: A Study to Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis [Phase 2]

View source ↗

Summary

Phase 2 study update assessing the repeatability of organ-level uptake of the radiopharmaceutical AT-01 labeled with iodine-124 in subjects with systemic amyloi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Amyloidosis

Drugs mentioned

• AT-01 (Iodine-124 labeled AT-01)

Snippet

Sponsor: Attralus, Inc. | Conditions: Amyloidosis | Phase 2 | Status: COMPLETED | Results posted: 2025-09-04